| scholarly article | Q13442814 |
| P50 | author | Merlin Thomas | Q56991969 |
| Milla Rosengård-Bärlund | Q41508293 | ||
| Ville-Petteri Mäkinen | Q42630492 | ||
| Lena M Thorn | Q57050235 | ||
| Per-Henrik Groop | Q64495494 | ||
| FinnDiane Study Group | Q64495495 | ||
| Carol Forsblom | Q73543623 | ||
| Outi Saarenpää-Heikkilä | Q90550264 | ||
| Kustaa Hietala | Q117234120 | ||
| Markku Saraheimo | Q117234129 | ||
| P2093 | author name string | John L Moran | |
| Johan Wadèn | |||
| P2860 | cites work | Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. | Q51921253 |
| A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. | Q52891030 | ||
| Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 | ||
| Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study | Q28188027 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Blood pressure lowering for the prevention and treatment of diabetic kidney disease. | Q30358393 | ||
| Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study | Q30789138 | ||
| Prevalence of asymptomatic myocardial ischaemia in diabetic subjects | Q35169887 | ||
| Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration | Q35824203 | ||
| The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. | Q36198724 | ||
| Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. | Q36600524 | ||
| Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland | Q37119215 | ||
| Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? | Q37932424 | ||
| Albuminuria reflects widespread vascular damage. The Steno hypothesis. | Q38672988 | ||
| Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
| The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study | Q40388803 | ||
| Can clinical factors estimate insulin resistance in type 1 diabetes? | Q40759534 | ||
| Long-term predictors of coronary artery disease and mortality in type 1 diabetes | Q43796780 | ||
| Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease | Q43841703 | ||
| Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study | Q44209360 | ||
| Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). | Q44248797 | ||
| Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients | Q44556266 | ||
| Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes | Q44994691 | ||
| An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes | Q45269868 | ||
| Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study | Q46093718 | ||
| Relationship between lipid profiles and kidney function in patients with type 1 diabetes | Q46906814 | ||
| Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy | Q47647645 | ||
| Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? | Q47854203 | ||
| Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes | Q48006848 | ||
| Long-Term Mortality and Incidence of Renal Dialysis and Transplantation in Type 1 Diabetes Mellitus | Q61817217 | ||
| Intraventricular septal hypertrophy in type 1 diabetic patients with microalbuminuria or early proteinuria | Q68410974 | ||
| Multiple lipoprotein abnormalities in type I diabetic patients with renal disease | Q71150193 | ||
| Endothelial dysfunction precedes development of microalbuminuria in IDDM | Q72189462 | ||
| Anemia in patients with type 1 diabetes | Q80542260 | ||
| ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification | Q81159143 | ||
| Urinary oxidative stress markers in young patients with type 1 diabetes | Q82611259 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| chronic renal insufficiency | Q736715 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1651-1658 | |
| P577 | publication date | 2009-04-28 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes | |
| P478 | volume | 58 |
| Q45972129 | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q63865921 | A new strategy for vascular complications in young people with type 1 diabetes mellitus |
| Q43523872 | ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes |
| Q40413586 | Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies |
| Q35129538 | Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for diabetes in youth study |
| Q40671262 | Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study |
| Q35407916 | Age and sex influence cystatin C in adolescents with and without type 1 diabetes |
| Q40503443 | Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study |
| Q30369623 | Alterations of urinary metabolite profile in model diabetic nephropathy. |
| Q51360467 | An independent effect of parental lipids on the offspring lipid levels in a cohort of adolescents with type 1 diabetes. |
| Q35950003 | Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes |
| Q35012749 | Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality |
| Q40915559 | Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus |
| Q64103823 | Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population |
| Q46335942 | Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes |
| Q50987471 | CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. |
| Q38086802 | Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes? |
| Q64245997 | Cardiovascular Health Benefits of Exercise Training in Persons Living with Type 1 Diabetes: A Systematic Review and Meta-Analysis |
| Q33711038 | Cardiovascular complications of diabetic kidney disease. |
| Q30239971 | Cardiovascular complications of type 1 diabetes: update on the renal link |
| Q38001360 | Cardiovascular risk in double diabetes mellitus--when two worlds collide |
| Q38502143 | Care of diabetes in children and adolescents: controversies, changes, and consensus |
| Q40311664 | Cause-specific mortality in a cohort of Brazilian patients with type 1 diabetes. |
| Q36969372 | Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond |
| Q38860630 | Challenges in pancreas transplantation. |
| Q37331337 | Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study |
| Q26749494 | Clinical Predictive Factors in Diabetic Kidney Disease Progression |
| Q49858996 | Clinical and pathological factors associated with progression of diabetic nephropathy. |
| Q40303186 | Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria |
| Q44558885 | Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy |
| Q97682132 | Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes |
| Q36876230 | Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy |
| Q34695419 | Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria |
| Q57606405 | Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes |
| Q92815247 | Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy? |
| Q36355894 | Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes |
| Q41198632 | Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes |
| Q37272437 | Defining cell-type specificity at the transcriptional level in human disease |
| Q27687598 | Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report |
| Q28385891 | Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study |
| Q54272064 | Diabetes. Excess mortality in well-controlled T1DM without renal disease. |
| Q86519469 | Diabetes: Elevated risk of mortality in type 1 diabetes mellitus |
| Q88112324 | Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes |
| Q35953872 | Diabetic Kidney Disease: Much Progress, But Still More to Do |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q41993558 | Diabetic Nephropathy: a Tangled Web to Unweave |
| Q34214578 | Diabetic kidney disease in children and adolescents |
| Q43721013 | Diabetic kidney disease. |
| Q27012546 | Diabetic kidney disease: a report from an ADA Consensus Conference |
| Q90429607 | Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patient |
| Q46009536 | Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? |
| Q38150065 | Diabetic nephropathy: diagnosis and treatment |
| Q38338539 | Diabetic nephropathy: landmark clinical trials and tribulations |
| Q48131380 | Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes |
| Q40403746 | Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). |
| Q64116567 | Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model |
| Q40599056 | Earlier intensified insulin treatment of Type 1 diabetes and its association with long-term macrovascular and renal complications |
| Q27021632 | Early diabetic nephropathy in type 1 diabetes: new insights |
| Q35591301 | Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy. |
| Q99569227 | Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials |
| Q34433105 | Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study |
| Q38075029 | Emerging drugs for managing kidney disease in patients with diabetes. |
| Q84498334 | EnRAGEd about death in type 1 diabetes |
| Q37806614 | Endothelial dysfunction as a potential contributor in diabetic nephropathy |
| Q96951726 | Engineering immunomodulatory biomaterials for type 1 diabetes |
| Q39115570 | Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative |
| Q50200240 | Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. |
| Q28254978 | Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010 |
| Q64262698 | Evolving spectrum of diabetic nephropathy |
| Q28081005 | Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles |
| Q52800957 | Expression of CD4+ CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: Relation to microvascular complications, aortic elastic properties, and carotid intima media thickness. |
| Q92801518 | Factors associated with resistance to complications in long-standing type 1 diabetes in China |
| Q35738502 | Foam cells and the pathogenesis of kidney disease |
| Q50990745 | Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes. |
| Q92547609 | Functional methylome analysis of human diabetic kidney disease |
| Q59436384 | Gender, metabolic control and carotid intima-media-thickness in children and adolescents with type 1 diabetes mellitus |
| Q92374894 | Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease |
| Q35405420 | Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes |
| Q57606433 | Genetics of Diabetic Micro- and Macrovascular Complications |
| Q94600785 | Genetics of diabetes mellitus and diabetes complications |
| Q57591416 | Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes |
| Q34024295 | Getting a notch closer to understanding diabetic kidney disease |
| Q39112475 | Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment |
| Q37801858 | Glycation in diabetic nephropathy |
| Q84813040 | HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes |
| Q35976961 | HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study |
| Q37110516 | Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study |
| Q40531970 | High hemoglobin A1c variability is associated with early risk of microalbuminuria in children with T1D. |
| Q51539273 | Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. |
| Q33715745 | Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury. |
| Q52686578 | Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study). |
| Q37106389 | Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study |
| Q64126098 | Improved early risk stratification with cystatin C-based estimated GFR |
| Q61948356 | Improved prognosis of diabetic nephropathy in type 1 diabetes |
| Q34641067 | Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort |
| Q34669819 | In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. |
| Q50048667 | Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria. |
| Q40503396 | Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes |
| Q37636864 | Influence of lifestyle on the course of type 1 diabetes mellitus |
| Q38092010 | Is the risk and nature of CVD the same in type 1 and type 2 diabetes? |
| Q36574770 | Kidney disease and increased mortality risk in type 2 diabetes |
| Q37403183 | Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study |
| Q26825227 | Kidney disease: new technologies translate mechanisms to cure |
| Q41508250 | Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study |
| Q91198847 | Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes |
| Q41553095 | Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications |
| Q51181930 | Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: the impact of renal disease. |
| Q39196199 | Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay |
| Q35910466 | Management of Type 1 Diabetes in Older Adults. |
| Q57606400 | Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes |
| Q37260216 | Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease |
| Q38612545 | Microbubbles and Ultrasound: Therapeutic Applications in Diabetic Nephropathy |
| Q47735079 | Modelling diabetic nephropathy in mice. |
| Q90045053 | Molecular form and concentration of serum α2-macroglobulin in diabetes |
| Q38268270 | Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now? |
| Q53577850 | Mortality and extent of coronary artery disease in 2776 patients with type 1 diabetes undergoing coronary angiography: A nationwide study. |
| Q40653191 | Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population |
| Q37899907 | New approaches to the treatment of nephropathy in diabetes |
| Q26786923 | Non-Proteinuric Diabetic Nephropathy |
| Q51083114 | Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification. |
| Q36942172 | Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes |
| Q37735321 | PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study |
| Q40085871 | Parity and mortality in cases of childhood-onset diabetes mellitus |
| Q92452498 | Physical Activity in the Prevention of Development and Progression of Kidney Disease in Type 1 Diabetes |
| Q47142090 | Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner |
| Q33621582 | Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management |
| Q34407459 | Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life |
| Q35446651 | Predicting major outcomes in type 1 diabetes: a model development and validation study |
| Q36793264 | Predictors of and survival after incident stroke in type 1 diabetes |
| Q33789640 | Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative |
| Q38666896 | Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies |
| Q90212904 | Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up |
| Q57606412 | Progress in Defining the Genetic Basis of Diabetic Complications |
| Q35248154 | Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy |
| Q34718404 | Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study). |
| Q44746520 | Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men. |
| Q36816866 | Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes |
| Q40818308 | Recent trends in life expectancy for people with type 1 diabetes in Sweden. |
| Q54389090 | Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. |
| Q50104171 | Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study. |
| Q57160525 | Relationship between High Level of Estimated Glomerular Filtration Rate and Contrast-Induced Acute Kidney Injury in Patients who Underwent an Emergency Percutaneous Coronary Intervention |
| Q34762311 | Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes |
| Q43663371 | Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus |
| Q53667904 | Renal transplantation in type 1 diabetes mellitus: an unusual case report. |
| Q50101784 | Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes. |
| Q38810827 | Retinal vascular imaging technology to monitor disease severity and complications in type 1 diabetes mellitus: A systematic review |
| Q58578856 | Risk Factor Modeling for Cardiovascular Disease in Type I Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison to the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat |
| Q64911710 | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes. |
| Q89465079 | Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes |
| Q55332246 | Serum uric acid and renal function in patients with type 1 diabetes: a nationwide study in Brazil. |
| Q35022648 | Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism. |
| Q37228311 | Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study |
| Q55379221 | Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 Diabetes. |
| Q37528633 | Sodium and Its Role in Cardiovascular Disease - The Debate Continues. |
| Q58708114 | Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy |
| Q84183344 | Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes |
| Q64912818 | Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes. |
| Q35957661 | Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study). |
| Q99241011 | Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy |
| Q92942816 | TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy |
| Q37064114 | Temporal trends in the prevalence of diabetic kidney disease in the United States |
| Q91783536 | The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up |
| Q36511434 | The Chronic Kidney Disease Epidemiology Collaboration equation improves the detection of hyperfiltration in Chinese diabetic patients |
| Q30275890 | The Genetic Landscape of Renal Complications in Type 1 Diabetes |
| Q57072601 | The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders |
| Q38786133 | The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease. |
| Q90685939 | The Susceptibility Genes in Diabetic Nephropathy |
| Q34718385 | The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes |
| Q37331253 | The changing face of young-onset diabetes: type 1 optimism mellowed by type 2 concerns |
| Q37760090 | The clinical significance of hyperfiltration in diabetes |
| Q36192161 | The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter? |
| Q38396875 | The genetics of diabetic complications |
| Q37590421 | The genetics of diabetic nephropathy. |
| Q35023627 | The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis |
| Q38200957 | The pathobiology of diabetic vascular complications--cardiovascular and kidney disease |
| Q38826073 | The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes. |
| Q37997004 | The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes |
| Q37975222 | The timing of dialysis and kidney transplantation in type 1 diabetes |
| Q100750541 | The trials and tribulations of determining HbA1c targets for diabetes mellitus |
| Q35204393 | Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study |
| Q38424947 | Time trends in mortality rates in type 1 diabetes from 2002 to 2011. |
| Q27000491 | Type 1 diabetes |
| Q57943428 | Type 1 diabetes |
| Q34219439 | Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association |
| Q36988877 | Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study |
| Q26746921 | Urinary Markers of Tubular Injury in Early Diabetic Nephropathy |
| Q64981581 | Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension. |
| Q33902878 | Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease |
| Q50950531 | Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes. |
| Q36942114 | Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes |
| Q93222242 | Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy |
| Q46864128 | Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes |
| Q101121100 | Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes |
| Q53620509 | [Diabetic kidney disease - Update 2016]. |
Search more.